The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.

Abstract

BACKGROUND Neuroendocrine tumors (NETs) are commonly treated with multimodality therapy. The combination of capecitabine and temozolomide (CAPTEM) has been suggested as a treatment option for patients with metastatic NETs. We present our experience with CAPTEM. METHODS Data on NET patients who were placed on CAPTEM and received at least one cycle were… (More)
DOI: 10.1634/theoncologist.2015-0470

Topics

Cite this paper

@article{Ramirez2016TheRO, title={The Role of Capecitabine/Temozolomide in Metastatic Neuroendocrine Tumors.}, author={Robert J. A. Ramirez and David T. Beyer and Aman Chauhan and J. Philip Boudreaux and Yi-Zarn Wang and Eugene A. Woltering}, journal={The oncologist}, year={2016}, volume={21 6}, pages={671-5} }